US Patent Issued to Memorial Sloan Kettering Cancer Center on July 22 for "Methods of enhancing immunogenicity of poorly immunogenic antigen-specific vaccines using oral yeast beta-glucans" (New York Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,752, issued on July 22, was assigned to Memorial Sloan Kettering Cancer Center (New York).

"Methods of enhancing immunogenicity of poorly immunogenic antigen-specific vaccines using oral yeast beta-glucans" was invented by Nai-Kong Cheung (New York), Shakeel Modak (New York) and Govind Ragupathi (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods for enhancing the immunogenicity of a poorly immunogenic antigen-specific vaccine as well as methods for promoting diversification of the gut microbiome in a subject in need thereof comprising administering to the subject an effective amount of a beta-glucan extr...